- Conditions
- Chlamydia, Gonorrhea
- Interventions
- illumigene CT and NG assays, illumipro-10
- Device
- Lead sponsor
- Meridian Bioscience, Inc.
- Industry
- Eligibility
- 14 Years to 89 Years
- Enrollment
- 700 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014
- U.S. locations
- 3
- States / cities
- Aurora, Colorado • Fall River, Massachusetts • Philadelphia, Pennsylvania
Source: ClinicalTrials.gov public record
Updated Dec 6, 2017 · Synced May 21, 2026, 11:09 PM EDT